Əsas səhifə

Çap

Əks əlaqə

İnfo
Commercial versus home-made spacers in delivering bronchodilator therapy for acute therapy in children

Mündəricat

Commercial versus home-made spacers in delivering bronchodilator therapy for acute therapy in children

Sübutlu məlumatların xülasələri
29.08.2018 • Sonuncu dəyişiklik 29.08.2018
Editors

There may not be a difference between commercial versus home-made spacers for delivering bronchodilator therapy to children with acute asthma or lower airways obstruction attacks.

A Cochrane review included 6 studies with a total of 658 subjects. No significant differences were demonstrated between the two delivery methods in terms of need for hospital admission (RR 1.00, 95% CI 0.63 to 1.59; 1 study, n=400), change in oxygen saturation (SMD -0.03, 95% CI -0.39 to 0.33; 2 studies, n=120), peak expiratory flow rate (SMD 0.04, 95% CI -0.72 to 0.80; 2 studies, n=90), clinical score (WMD 0.00, 95% CI -0.37 to 0.37; 1 study, n=20), in terms of need for additional treatment (RR 1.18, 95% CI 0.84 to 1.65; 3 studies, n=552), or regarding change in heart rate per minute (SMD 0.09, 95% CI -0.24 to 0.42; 3 studies, n=140).

Comment: The quality of evidence is downgraded by indirectness (lack of data on clinically important outcomes) and by imprecise results (few patients and wide confidence intervals).

Ədəbiyyat

  1. Rodriguez C, Sossa M, Lozano JM. Commercial versus home-made spacers in delivering bronchodilator therapy for acute therapy in children. Cochrane Database Syst Rev 2008 Apr 16;(2):CD005536 [Review content assessed as up-to-date: 17 August 2010].